{"id":808,"date":"2016-09-23T11:42:57","date_gmt":"2016-09-23T11:42:57","guid":{"rendered":"http:\/\/tecnodiabetes.ai2.upv.es\/?page_id=808"},"modified":"2025-08-14T10:10:17","modified_gmt":"2025-08-14T08:10:17","slug":"insulaid2","status":"publish","type":"page","link":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/","title":{"rendered":"INSULAID2"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; fullwidth=\u00bbon\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb admin_label=\u00bbSecci\u00f3n\u00bb _builder_version=\u00bb4.16&#8243; background_color=\u00bb#f15d2f\u00bb custom_padding=\u00bb30px|||\u00bb custom_padding_tablet=\u00bb50px|0|50px|0&#8243; custom_padding_phone=\u00bb50px|0|50px|0&#8243; transparent_background=\u00bboff\u00bb padding_mobile=\u00bboff\u00bb make_fullwidth=\u00bboff\u00bb use_custom_width=\u00bboff\u00bb width_unit=\u00bbon\u00bb custom_width_px=\u00bb1080px\u00bb custom_width_percent=\u00bb80%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_fullwidth_code admin_label=\u00bbC\u00f3digo de anchura completa\u00bb _builder_version=\u00bb4.16&#8243; global_colors_info=\u00bb{}\u00bb].[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; custom_padding_last_edited=\u00bbon|desktop\u00bb admin_label=\u00bbSecci\u00f3n\u00bb _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb54px|0px|0px|0px\u00bb custom_padding_tablet=\u00bb50px|0|50px|0&#8243; custom_padding_phone=\u00bb50px|0|50px|0&#8243; transparent_background=\u00bboff\u00bb padding_mobile=\u00bboff\u00bb make_fullwidth=\u00bboff\u00bb use_custom_width=\u00bboff\u00bb width_unit=\u00bboff\u00bb custom_width_px=\u00bb1080px\u00bb custom_width_percent=\u00bb80%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb column_structure=\u00bb1_5,1_5,1_5,1_5,1_5&#8243; custom_margin=\u00bb-52px||||false|false\u00bb hover_enabled=\u00bb0&#8243; sticky_enabled=\u00bb0&#8243;][et_pb_column _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb type=\u00bb1_5&#8243;][\/et_pb_column][et_pb_column _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb type=\u00bb1_5&#8243;][\/et_pb_column][et_pb_column _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb type=\u00bb1_5&#8243;][\/et_pb_column][et_pb_column _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb type=\u00bb1_5&#8243;][\/et_pb_column][et_pb_column _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb type=\u00bb1_5&#8243;][et_pb_image src=\u00bbhttps:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2023\/01\/Logotipo_del_Ministerio_de_Educacion_y_Ciencia.png\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb alt=\u00bbMinisterio de Educaci\u00f3n y Ciencia\u00bb title_text=\u00bbMinisterio de Educaci\u00f3n y Ciencia\u00bb hover_enabled=\u00bb0&#8243; sticky_enabled=\u00bb0&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row padding_mobile=\u00bboff\u00bb column_padding_mobile=\u00bbon\u00bb admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.27.4&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb hover_enabled=\u00bb0&#8243; make_fullwidth=\u00bboff\u00bb use_custom_width=\u00bboff\u00bb width_unit=\u00bboff\u00bb custom_width_px=\u00bb1080px\u00bb custom_width_percent=\u00bb80%\u00bb global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243; custom_margin=\u00bb-20px||||false|false\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.16&#8243; text_font=\u00bb|||on|\u00bb background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb text_orientation=\u00bbcenter\u00bb module_alignment=\u00bbcenter\u00bb use_border_color=\u00bboff\u00bb border_style=\u00bbsolid\u00bb saved_tabs=\u00bball\u00bb inline_fonts=\u00bbMontserrat\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h4><span style=\"font-family: Montserrat; color: #999999;\" data-mce-style=\"font-family: Montserrat; color: #999999;\">PROYECTOS\u00a0<\/span><\/h4>\n<h3>INSULAID2<br \/><\/h3>\n<p><span style=\"font-family: Montserrat; font-size: large;\" data-mce-style=\"font-family: Montserrat; font-size: large;\">Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes Cr\u00edticos<\/span><br data-mce-bogus=\"1\"><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2&#8243; padding_mobile=\u00bboff\u00bb column_padding_mobile=\u00bbon\u00bb admin_label=\u00bbFila\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb make_fullwidth=\u00bboff\u00bb use_custom_width=\u00bboff\u00bb width_unit=\u00bboff\u00bb custom_width_px=\u00bb1080px\u00bb custom_width_percent=\u00bb80%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_image src=\u00bbhttp:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2016\/11\/insulaid2-logo-color-fondoblanco-peque\u00a7o.png\u00bb align_tablet=\u00bbcenter\u00bb align_phone=\u00bbcenter\u00bb align_last_edited=\u00bbon|desktop\u00bb admin_label=\u00bbImagen\u00bb _builder_version=\u00bb4.16&#8243; animation_style=\u00bbslide\u00bb animation_direction=\u00bbleft\u00bb animation_duration=\u00bb500ms\u00bb animation_intensity_slide=\u00bb10%\u00bb use_border_color=\u00bboff\u00bb border_color=\u00bb#ffffff\u00bb border_width=\u00bb1px\u00bb border_style=\u00bbsolid\u00bb sticky=\u00bboff\u00bb always_center_on_mobile=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_2&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb use_border_color=\u00bboff\u00bb border_color=\u00bb#ffffff\u00bb border_style=\u00bbsolid\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h4>Datos administrativos<\/h4>\n<p><strong>Referencia del proyecto:<\/strong> DPI2007-66728-C02-01<br \/><strong>T\u00edtulo:<\/strong> Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes&nbsp;<span style=\"font-size: 14px;\" data-mce-style=\"font-size: 14px;\">cr\u00edticos<br \/><\/span><span style=\"font-size: 14px;\" data-mce-style=\"font-size: 14px;\"><strong>Entidades participantes:<\/strong> Proyecto coordinado <br \/><strong>Subproyecto 1:<\/strong> Universitat Polit\u00e8cnica de Val\u00e8ncia (coordinador); <strong>Subproyecto 2:<\/strong> Universitat de Girona<br \/><\/span><strong>Investigador principal:<\/strong> Jorge Bondia (coordinador); Josep Veh\u00ed<br \/><strong>Entidad financiadora:<\/strong> Ministerio de Educaci\u00f3n y Ciencia<br \/><strong>Duraci\u00f3n:<\/strong> 01\/10\/2007-01\/10\/2011<br \/><strong>Financiaci\u00f3n recibida:<\/strong> Subproyecto 1: 195.415,00\u20ac; <br \/>Subproyecto 2: 206.063,00\u20ac<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row padding_mobile=\u00bboff\u00bb column_padding_mobile=\u00bbon\u00bb admin_label=\u00bbFila\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_padding=\u00bb27px|0px|0px|0px\u00bb make_fullwidth=\u00bboff\u00bb use_custom_width=\u00bboff\u00bb width_unit=\u00bboff\u00bb custom_width_px=\u00bb1080px\u00bb custom_width_percent=\u00bb80%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb use_border_color=\u00bboff\u00bb border_style=\u00bbsolid\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h4>Resumen del proyecto<\/h4>\n<p>En la d\u00e9cada de los 90, se demostr\u00f3 que cualquier mejora en el control gluc\u00e9mico se traduce en una reducci\u00f3n del riesgo de desarrollar las complicaciones cr\u00f3nicas asociadas a la diabetes. Por esta raz\u00f3n, la normoglucemia se ha convertido en el objetivo de control de los pacientes afectos de diabetes mellitus 1. Por otra parte, el paciente cr\u00edtico en la Unidad de Cuidados Intensivos est\u00e1 sujeto a una gran morbilidad y mortalidad. Los \u00faltimos avances en el conocimiento de la fisiopatolog\u00eda de estos pacientes demuestran como la hiperglucemia puede contribuir sobre la evoluci\u00f3n cl\u00ednica. Existe literatura que orienta hacia la importancia de conseguir normoglucemia en estos pacientes mediante perfusiones de insulina para reducir la mortalidad. Existe por tanto un gran inter\u00e9s social y econ\u00f3mico en el control eficaz de la glucemia.<\/p>\n<p>Se espera que en 4 o 5 a\u00f1os la tecnolog\u00eda necesaria para un control autom\u00e1tico de la glucemia est\u00e9 disponible, siendo actualmente los sensores continuos de glucosa un factor limitante. Es por tanto de primordial importancia el estudio de algoritmos de control de glucemia eficaces, el desarrollo de buenos modelos del sistema glucorregulatorio y su validaci\u00f3n a partir de criterios terap\u00e9uticos.<\/p>\n<p>Se plantean por tanto en este proyecto dos objetivos globales: (1) la implementaci\u00f3n de un estudio cl\u00ednico para la obtenci\u00f3n de datos experimentales que permitan el desarrollo de modelos y su validaci\u00f3n terap\u00e9utica; (2) el desarrollo de algoritmos de control avanzados para el control en lazo cerrado de la glucemia en pacientes con DM1 y pacientes cr\u00edticos.<\/p>\n<p>Se emplear\u00e1n t\u00e9cnicas intervalares y conjuntistas para abordar el problema de la variabilidad intra e interpaciente. Finalmente se explorar\u00e1 el uso de se\u00f1ales contrarreguladoras como el glucag\u00f3n o glucosa adem\u00e1s de la insulina en el control.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row padding_mobile=\u00bboff\u00bb column_padding_mobile=\u00bbon\u00bb admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_padding=\u00bb25.5px|0px|17px|0px\u00bb make_fullwidth=\u00bboff\u00bb use_custom_width=\u00bboff\u00bb width_unit=\u00bboff\u00bb custom_width_px=\u00bb1080px\u00bb custom_width_percent=\u00bb80%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb use_border_color=\u00bboff\u00bb border_style=\u00bbsolid\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h4>Investigadores<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3&#8243; padding_mobile=\u00bboff\u00bb column_padding_mobile=\u00bbon\u00bb admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_padding=\u00bb0px|0px|25.5px|0px\u00bb make_fullwidth=\u00bboff\u00bb use_custom_width=\u00bboff\u00bb width_unit=\u00bboff\u00bb custom_width_px=\u00bb1080px\u00bb custom_width_percent=\u00bb80%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb use_border_color=\u00bboff\u00bb border_style=\u00bbsolid\u00bb global_colors_info=\u00bb{}\u00bb]<H6>Universitat Polit\u00e8cnica de Val\u00e8ncia:<\/H6><\/p>\n<ul>\n<li>Jorge Bondia (coordinador)<\/li>\n<li>Jos\u00e9 Luis D\u00edez<\/li>\n<li>Sergio Romero<\/li>\n<li>Beatriz Ricarte<\/li>\n<li>Cristina Tar\u00edn<\/li>\n<li>F\u00e1tima Barcel\u00f3<\/li>\n<li>Alejandro Laguna<\/li>\n<li>Ana Revert<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb use_border_color=\u00bboff\u00bb border_style=\u00bbsolid\u00bb global_colors_info=\u00bb{}\u00bb]<H6>Universitat de Girona<\/strong><\/H6><\/p>\n<ul>\n<li>Josep Veh\u00ed (co-IP)<\/li>\n<li>Remei Calm<\/li>\n<li>\n<p style=\"margin-bottom: 0cm;\" data-mce-style=\"margin-bottom: 0cm;\">Miguel \u00c1ngel Sainz<\/p>\n<\/li>\n<li>\n<p style=\"margin-bottom: 0cm;\" data-mce-style=\"margin-bottom: 0cm;\">Maira Garc\u00eda-Jaramillo<\/p>\n<\/li>\n<li>Fabi\u00e1n Le\u00f3n<\/li>\n<li>Yenny Leal<\/li>\n<li>Cris\u00f3stomo A. Barajas<\/li>\n<li>Darine Zambrano<\/li>\n<li>Winston M. Garc\u00eda Gab\u00edn<\/li>\n<li>Oscar Olarte<\/li>\n<\/ul>\n<p><\/p>\n<ul>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbTexto\u00bb _builder_version=\u00bb4.16&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb use_border_color=\u00bboff\u00bb border_style=\u00bbsolid\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h6>Hospital Cl&iacute;nico de Valencia<\/h6>\n<ul>\n<li>F. Javier Ampudia<\/li>\n<\/ul>\n<h6>Hospital Francesc de Borja de Gand&iacute;a<\/h6>\n<ul>\n<li>Paolo Rossetti<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PROYECTOS\u00a0 INSULAID2 Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes Cr\u00edticos Datos administrativos Referencia del proyecto: DPI2007-66728-C02-01T\u00edtulo: Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes&nbsp;cr\u00edticosEntidades participantes: Proyecto coordinado Subproyecto 1: Universitat Polit\u00e8cnica de Val\u00e8ncia (coordinador); Subproyecto 2: Universitat de GironaInvestigador principal: Jorge Bondia [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"class_list":["post-808","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Proyecto de p\u00e1ncreas artificial INSULAID2 - Tecnodiabetes<\/title>\n<meta name=\"description\" content=\"Conoce el proyecto INSULAID2 &quot;Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes cr\u00edticos&quot;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proyecto de p\u00e1ncreas artificial INSULAID2 - Tecnodiabetes\" \/>\n<meta property=\"og:description\" content=\"Conoce el proyecto INSULAID2 &quot;Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes cr\u00edticos&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/\" \/>\n<meta property=\"og:site_name\" content=\"Tecnodiabetes\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Tecnodiabetes-1788690764738148\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-14T08:10:17+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@tecnodiabetes\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/insulaid2\\\/\",\"url\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/insulaid2\\\/\",\"name\":\"Proyecto de p\u00e1ncreas artificial INSULAID2 - Tecnodiabetes\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/#website\"},\"datePublished\":\"2016-09-23T11:42:57+00:00\",\"dateModified\":\"2025-08-14T08:10:17+00:00\",\"description\":\"Conoce el proyecto INSULAID2 \\\"Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes cr\u00edticos\\\"\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/insulaid2\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/insulaid2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/insulaid2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INSULAID2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/#website\",\"url\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/\",\"name\":\"Tecnodiabetes\",\"description\":\"Divulgaci\u00f3n Cient\u00edfica sobre Diabetes\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Proyecto de p\u00e1ncreas artificial INSULAID2 - Tecnodiabetes","description":"Conoce el proyecto INSULAID2 \"Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes cr\u00edticos\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/","og_locale":"es_ES","og_type":"article","og_title":"Proyecto de p\u00e1ncreas artificial INSULAID2 - Tecnodiabetes","og_description":"Conoce el proyecto INSULAID2 \"Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes cr\u00edticos\"","og_url":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/","og_site_name":"Tecnodiabetes","article_publisher":"https:\/\/www.facebook.com\/Tecnodiabetes-1788690764738148\/","article_modified_time":"2025-08-14T08:10:17+00:00","twitter_card":"summary_large_image","twitter_site":"@tecnodiabetes","twitter_misc":{"Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/","url":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/","name":"Proyecto de p\u00e1ncreas artificial INSULAID2 - Tecnodiabetes","isPartOf":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/#website"},"datePublished":"2016-09-23T11:42:57+00:00","dateModified":"2025-08-14T08:10:17+00:00","description":"Conoce el proyecto INSULAID2 \"Control de glucemia en lazo cerrado en pacientes con diabetes mellitus 1 y pacientes cr\u00edticos\"","breadcrumb":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/insulaid2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/tecnodiabetes.ai2.upv.es\/"},{"@type":"ListItem","position":2,"name":"INSULAID2"}]},{"@type":"WebSite","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/#website","url":"https:\/\/tecnodiabetes.ai2.upv.es\/","name":"Tecnodiabetes","description":"Divulgaci\u00f3n Cient\u00edfica sobre Diabetes","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tecnodiabetes.ai2.upv.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/pages\/808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/comments?post=808"}],"version-history":[{"count":12,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/pages\/808\/revisions"}],"predecessor-version":[{"id":3748,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/pages\/808\/revisions\/3748"}],"wp:attachment":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/media?parent=808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}